Stock listing

Frankfurt:5YI Nyxoah SA Aktie

German listing (Frankfurt) of Nyxoah SA · home listing Euronext:NYXH

Follow Nyxoah SA into a list and get an email when it puts out news.

Share price · FWB:5YI

€0.741 EUR -0.028 (-3.6%)

Close on Nov 20, 2026

Past year -80.9% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€0.741 – €0.780 EURNov 20, 2026
Market cap
€75.46M EURAt the close on Nov 20, 2026 · price × 101.8M shares outstanding
52-week range
€0.590 – €4.535 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€1,915 EURMedian day 0 shares · 46 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Nyxoah SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:NYXH · Home€0.748 EUR-0.041 (-5.2%)168,928€0.810€0.810€0.740€0.789Close on Nov 20, 2026
NASDAQ:NYXH$0.805 USD-0.054 (-6.3%)97,550$0.850$0.850$0.800$0.859Close on Nov 20, 2026
Frankfurt:5YI€0.741 EUR-0.028 (-3.6%)—€0.780€0.780€0.741€0.769Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:5YI · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.720-0.037-4.9%€0.750€0.754€0.7200
€0.757-0.030-3.8%€0.758€0.759€0.7570
€0.787+0.017+2.2%€0.757€0.788€0.7240
€0.770+0.006+0.8%€0.774€0.778€0.7600
€0.764-0.006-0.8%€0.765€0.765€0.7590
€0.770-0.025-3.1%€0.802€0.802€0.7688,000
€0.795-0.025-3.0%€0.835€0.839€0.7908,380
€0.820+0.160+24.2%€0.883€0.887€0.81712,332
€0.660+0.061+10.2%€0.633€0.667€0.6310
€0.599-0.026-4.2%€0.720€0.720€0.59012,332
€0.625-0.208-25.0%€0.711€0.713€0.5970
€0.833+0.123+17.3%€0.833€0.833€0.8330
€0.710-0.100-12.3%€0.850€0.853€0.7090
€0.810-0.011-1.3%€0.821€0.830€0.8100
€0.821-0.103-11.1%€0.972€0.973€0.8130
€0.924+0.019+2.1%€1.041€1.047€0.9230
€0.905-0.087-8.8%€1.073€1.083€0.8980
€0.992-0.022-2.2%€1.119€1.120€0.9840
€1.014-0.025-2.4%€1.126€1.129€1.0060
€1.039-0.038-3.5%€1.190€1.196€1.0300
€1.077-0.027-2.4%€1.168€1.170€1.0755,160
€1.104-0.023-2.0%€1.259€1.269€1.0990
€1.127-0.022-1.9%€1.237€1.245€1.0990
€1.149+0.068+6.3%€1.209€1.211€1.1280
€1.081+0.034+3.2%€1.160€1.161€1.0640
€1.047-0.016-1.5%€1.147€1.149€1.04524,000
€1.063-0.021-1.9%€1.180€1.181€1.0560
€1.084-0.069-6.0%€1.204€1.207€1.0830
€1.153-0.130-10.1%€1.372€1.373€1.1440
€1.283+0.224+21.2%€1.244€1.284€1.1760
€1.059+0.036+3.5%€1.113€1.115€1.006500
€1.023-0.090-8.1%€1.147€1.147€1.0160
€1.113-0.007-0.6%€1.237€1.245€1.1050
€1.120-0.336-23.1%€1.264€1.272€1.1170
€1.456+0.255+21.2%€1.276€1.459€1.1573,000
€1.201-0.002-0.2%€1.301€1.303€1.194480
€1.203-0.039-3.1%€1.334€1.346€1.1880
€1.242+0.039+3.2%€1.324€1.337€1.1950
€1.203-0.030-2.4%€1.341€1.345€1.2000
€1.233+0.027+2.2%€1.311€1.314€1.2310
€1.206+0.027+2.3%€1.272€1.272€1.199400
€1.179-0.041-3.4%€1.297€1.306€1.1600
€1.220-0.077-5.9%€1.369€1.383€1.2130
€1.297+0.013+1.0%€1.383€1.384€1.2900
€1.284-0.067-5.0%€1.453€1.455€1.2790
€1.351-0.054-3.8%€1.451€1.452€1.34731,228
€1.405+0.225+19.1%€1.405€1.405€1.4050
€1.180-0.036-3.0%€1.292€1.294€1.1590
€1.216-0.081-6.2%€1.346€1.350€1.2110
€1.297+0.037+2.9%€1.397€1.400€1.2780
€1.260-0.024-1.9%€1.379€1.389€1.2550
€1.284-0.059-4.4%€1.399€1.400€1.2790
€1.343+0.056+4.4%€1.390€1.391€1.2850
€1.287-0.009-0.7%€1.382€1.397€1.2860
€1.296-0.003-0.2%€1.374€1.374€1.2550
€1.299+0.016+1.2%€1.396€1.396€1.2920
€1.283-0.014-1.1%€1.403€1.413€1.2680
Ticker
Frankfurt:5YI
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Nyxoah (Euronext:NYXH) Q3 2026 Earnings Call

    Thu, Nov 05, 2026 · 4:30 PM ET

    Watch Transcript
  • Nyxoah (Euronext:NYXH) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 4:30 PM ET

    Watch Transcript
  • Nyxoah (Euronext:NYXH) Q1 2026 Earnings Call

    Tue, May 12, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

All Nyxoah SA news

Financings

  • Public offering of equity financing

    Jun 10, 2026

    Closed: US$95M raised · US$1.72 a share · BofA Securities +2

    Dealers: BofA Securities (lead), Bank Degroof Petercam SA/NV, B. Riley

    Insiders: strong insider participation

    Use of proceeds: Accelerate the U.S. commercialization of Genio

    Closed Jun 10, 2026

  • Private placement of new ordinary shares

    Nov 14, 2025 · US$19.76M

    Announced: €17M · €4 a share · Degroof Petercam

    Dealers: Degroof Petercam (lead)

    Buyers: Robert Taub; Jürgen Hambrecht; Daniel Wildman; Olivier Taelman; John Landry; Scott Holstine

    Insiders: Chairman, independent directors, CEO, CFO and Chief Commercial Officer together subscribed to 356,250 new shares for EUR 1.425 million

    Use of proceeds: US and international commercialization of Genio, clinical data, R&D, new technologies pipeline and general corporate purposes

    Announced Nov 14, 2025

  • Registered direct offering of new ordinary shares

    Nov 14, 2025

    Announced: about US$5.6M · US$4.6304 a share

    Announced Nov 14, 2025

  • Convertible bonds

    Nov 14, 2025 · US$52.3M

    Announced: up to €45M

    Use of proceeds: US and international commercialization of Genio, clinical data, R&D, new technologies pipeline and general corporate purposes

    Announced Nov 14, 2025

Read by 6ix AI from the company's releases

Decks

Nyxoah SA on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
34 in the last 12 months · 52 in all · newest Sep 28, 2026 · oldest 2025
Calls
19 calls with a replay · 19 with a transcript · latest Nov 5, 2026
Decks
16 decks · latest September 2026

Where Nyxoah SA is listed

ListingExchangeCountryCurrency
Euronext:NYXH · Home listingEuronextBelgiumEUR
NASDAQ:NYXHNASDAQUnited StatesUSD
gettex:5YIgettexGermanyEUR
LS Exchange:A2QCWKLS ExchangeGermanyEUR
Lang & Schwarz:A2QCWKLang & SchwarzGermanyEUR
BOATS:NYXHBOATSUnited StatesUSD
Stuttgart:5YIStuttgartGermanyEUR
Aquis:NYXHBAquisUnited KingdomEUR
Aquis:NYXHBAquisUnited KingdomEUR
Dusseldorf:5YIDusseldorfGermanyEUR
Frankfurt:5YI · This pageFrankfurtGermanyEUR
Munich:5YIMunichGermanyEUR

Log in to ask 6ix AI your own questions about Nyxoah SA.